Nanoparticles treat muscular dystrophy in mice

Researchers at the School of Medicine have demonstrated a new approach to treating muscular dystrophy. Mice with a form of the disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.